Details for 2016815375

Up to date per 03.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON KAPOSI-SARKOM ODER KSVH-INDUZIERTEM LYMPHOM UNTER VERWENDUNG IMMUNMODULATORISCHER VERBINDUNGEN UND VERWENDUNGEN VON BIOMARKERN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016815375

EP Publication Number

3313818

E-Number

1629522

Language

PCT Number

US16039245

Publication Date

02.05.2018 A

08.11.2023 B1

Registration Date

08.11.2023

AT Publication Date

15.11.2023

Application Date

24.06.2016

Registration Number

Priorities

26.06.2015

201562185265 P

IPC

C07D 209/48 20060101AFI20181217BHEP

Maximum Duration of Protection

24.06.2036

Owner

Celgene CorporationRoute 206 & Province Line Road Princeton, NJ 08543US

The U.S.A. as represented by the Secretary, Department of Health and Human Services Office of Technology Transfer National Institutes of Health6011 Executive Boulevard, Suite 325, MSC 7660 Bethesda, MD 20892-7660 US

Representative

Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT

Inventor

YARCHOAN, Robert9007 Burning Tree Road Bethesda, MD 20817US

ZELDIS, Jerome151 Library Place Princeton, NJ 08540US

POLIZZOTTO, Mark13 Oatley Road Apt. 8 Paddington, New South Wales 2021AU

DAVIS, David9821 Singleton Drive Bethesda, MD 20817US

SERETI, Irini616 E Street NW Apt. 1148 Washington, DC 20004US

ULDRICK, Thomas1400 Church Street NW 206 Washington, DC 20005US

WHITBY, Denise836 North Market Street Frederick, MD 21701US

KHETANI, Vikram328 Old Short Hills Road Short Hills, NJ 07078US

Information about Fees